SCHEMBL19629191

SCHEMBL19629191

CC1CCN(C(=O)/C=N/O)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.39
▸ HPGD P15428 4/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LMNA P02545 3/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ POLB P06746 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ACHE P22303 1/20 0.35
▸ DPP4 P27487 1/20 0.35
▸ DPP8 Q6V1X1 1/20 0.35
▸ DPP7 Q9UHL4 1/20 0.35
▸ RECQL P46063 1/20 0.34
▸ GAA P10253 2/20 0.34
▸ PHGDH O43175 1/20 0.33
▸ MGLL Q99685 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15726987 0.81 ALDH1A1 (0.41) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL1687958 0.81 ALDH1A1 (0.41) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL15080935 0.81 ALDH1A1 (0.41) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL10285827 0.77 LMNA (0.44) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL23997789 0.76 ALDH1A1 (0.47) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL27889775 0.73 ALDH1A1 (0.48) ALDH1A1NPC1SMN1; SMN2LMNAMEN1
SCHEMBL25206318 0.73 JAK3 (0.38) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL12142184 0.71 — —
SCHEMBL3409523 0.71 — —
SCHEMBL6037523 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10590498-B2 Compounds for reactivation of acetylcholinesterase and related compositions methods and systems LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) 2020-03-17 — — US disclosed
US-20170335415-A1 COMPOUNDS FOR REACTIVATION OF ACETYLCHOLINESTERASE AND RELATED COMPOSITIONS METHODS AND SYSTEMS LAWRENCE LIVERMORE NATIONAL SECURITY, LLC 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10590498-B2 Compounds for reactivation of acetylcholinesterase and related compositions methods and systems ACHE, BCHE, CHAT ALDH1A1 440/4885HPGD 470/4885NPC1 1591/4885
US-20170335415-A1 COMPOUNDS FOR REACTIVATION OF ACETYLCHOLINESTERASE AND RELATED COMPOSITIONS METHODS AND SYSTEMS ACHE, BCHE, CHAT ALDH1A1 440/4885HPGD 470/4885NPC1 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback